There are additional "add-on" workshops designed to augment the core conference content. These workshops facilitate networking and offer in-depth discussions on specific areas of interest.
The following adjunct workshops are offered at no cost to participants. Registration is separate from the conference and is handled by the workshop organizer.
Epigenetics to Practice
Post-conference workshop | Wednesday, Oct. 2, 12:30-6 p.m. | Mayo Clinic in Rochester, Minn.
This workshop will provide an overview of Mayo Clinic efforts to translate concepts and methodologies from the field of epigenomics to medical practice.
Emphasis will be given to present and discuss new discoveries in the areas of disease mechanisms, diagnostic and prognostic markers, and recent advances in the area of epigenetic pharmacology. Participants will gain insights into how the rapidly emerging field of epigenomics is being applied to modern medicine.
Course FeeFreeSign up by email
Though aberrant activation or inactivation of genes caused by mutations and deletions can have deleterious effects to organisms, this mechanism does not explain the majority of human diseases. In addition, genetic alterations are difficult to repair for therapeutic purposes.
Epigenetics, a rapidly emerging scientific discipline, seeks to define how individual genes are turned on and off independently of their mutational status to produce distinct normal and diseased phenotypes. Epigenomics, the genome-wide application of epigenetic techniques, is extending the power of genomics, proteomics and other high-throughput techniques for the analyses of complex disease phenotypes.
In addition, emerging data demonstrate that, contrary to genetic alterations, epigenetic changes are amenable to therapeutic intervention. Epigenomic markers are beginning to be used for diagnostic purposes in single individuals or in populations. Thus, concepts and methodology from the field of epigenomics are becoming part of the arsenal of tools available to practitioners to study, prevent and manage common human diseases.
The goal of this workshop is to educate the medical field at large on the application of this discipline to diagnose, manage, prevent and cure human diseases.
Who should attend
The format and content of this workshop seeks to inform the medical community at large, including practitioners, allied health personnel, students, and basic and clinical investigators, as well as ethicists and policymakers.
The format of the workshop will include lectures by Mayo Clinic investigators and guest speakers as well as poster sessions in an atmosphere that emphasizes participation and discussions.
At the end of the workshop, participants are expected to have gained an understanding of molecular mechanisms underlying epigenetic events; provide descriptions of tools for the design and execution of research in this discipline; discuss how to generate and analyze data; and more importantly, discuss the application of epigenomics to disease prevention, diagnostics and therapeutics.
- Tamas Ordog, M.D. Program Director, Epigenomics Translational Program Consultant and Associate Professor Mayo Clinic in Rochester, Minn.
- Raul A. Urrutia, M.D. Consultant and Assistant Professor Mayo Clinic in Rochester, Minn.
- Michael T. McCabe, Ph.D. Investigator GlaxoSmithKline Collegeville, Pa.
- Keith D. Robertson, Ph.D. Senior Associate Consultant Mayo Clinic in Rochester, Minn.
- Ali Shilatifard, Ph.D. Investigator Stowers Institute for Medical Research Kansas City, Mo.
- Johnathan R. Whetstine, Ph.D. Assistant Professor of Medicine Harvard Medical School and Massachusetts General Hospital Cancer Center Charlestown, Mass.
Microbiome — Promise to Practice
Post-conference workshop | Wednesday, Oct. 2, 12:30-5 p.m. | Mayo Clinic in Rochester, Minn.
The invention of the microscope long ago allowed us to understand how bacteria can cause and transmit infections in people. Now, using genomic sequencing, we are discovering that communities of bacteria, known as the human microbiome, do much more for us than we ever imagined.
Join us for a half-day workshop as we explore the interface between the microbiome and clinical treatments such as fecal microbiome transplants, nutritional interventions and probiotics.
Course FeeFreeSign up by email
Attendees will obtain state-of-the-art information regarding the translation of microbiome knowledge into medical practice. Emphasis will be placed on optimal 16S rRNA reporting tools, outcomes from current therapies with nutrition and fecal microbiome transplant, how germ-free animal studies and clinical trials inform Food and Drug Administration (FDA) applications, and the role of microbiome on xenobiotics.
Who should attend
- Health care providers interested in opportunities for promoting health and wellness through knowledge of the relationship between nutrition and the microbiome
- Clinical investigators with an interest in testing novel therapies including fecal microbiome transplant, targeted antibiotics, probiotics and nutrition interventions
- Scientists in the fields of microbiome, systems biology and bioinformatics with interest in developing clinical tools from microbiome research
To integrate microbiome knowledge with the medical practice to promote healthy living and offer new therapies for medical conditions
Specific goals include:
- Expand indications for fecal microbiome transplant therapy
- Determine optimal 16S rRNA reporting
- Identify nutrition interventions and clinical trial opportunities
- Establish the role of germ-free animal models and trials in FDA applications
- Consider the role of microbiome in drug therapy
- Peter Turnbaugh, Ph.D. FAS Center for Systems Biology Harvard University
- Nicholas Chia, Ph.D. Associate Consultant, Department of Surgery Mayo Clinic in Rochester, Minn.
- Darrell S. Pardi, M.D. Consultant, Division of Gastroenterology and Hepatology Mayo Clinic in Rochester, Minn.
- Purna C. Kashyap, MBBS Senior Associate Consultant, Division of Gastroenterology and Hepatology Mayo Clinic in Rochester, Minn.
- Kelly Tappenden, Ph.D., R.D. Professor, College of ACES University of Illinois at Urbana - Champaign